Recursion gets FDA approval to begin phase 1 trials of AI-discovered cancer treatment
Source: Recursion Pharmaceuticals AI drug pioneer Recursion Pharmaceuticals said Wednesday that one of its experimental treatments hit a key milestone. Recursion was able to use its artificial intelligence-enabled drug discovery …
